Natural antioxidant compounds in risk factors for CVD

The benefits of drug treating hypertension, hyperglycemia and hyperlipidemias in terms of reduction of CVD morbidity and mortality are well established. However, there is epidemiological evidence that consumption of certain foods results to a reduction in myocardial infarction markers. Given in many...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacological research 2007-08, Vol.56 (2), p.99-109
Main Authors: Kaliora, Andriana C., Dedoussis, George V.Z.
Format: Article
Language:English
Subjects:
Animals
Antihypertensive Agents - pharmacology
Antihypertensive Agents - therapeutic use
Antioxidants
Antioxidants - pharmacology
Antioxidants - therapeutic use
Cardiovascular Diseases - etiology
Cardiovascular Diseases - metabolism
Cardiovascular Diseases - physiopathology
Cardiovascular Diseases - prevention & control
CVD
Endothelium, Vascular - drug effects
Endothelium, Vascular - physiopathology
Human studies
Humans
Hyperglycemia
Hyperglycemia - complications
Hyperglycemia - drug therapy
Hyperglycemia - metabolism
Hyperglycemia - physiopathology
Hyperlipidemias
Hyperlipidemias - complications
Hyperlipidemias - drug therapy
Hyperlipidemias - metabolism
Hyperlipidemias - physiopathology
Hypertension
Hypertension - complications
Hypertension - drug therapy
Hypertension - metabolism
Hypertension - physiopathology
Hypoglycemic Agents - pharmacology
Hypoglycemic Agents - therapeutic use
Hypolipidemic Agents - pharmacology
Hypolipidemic Agents - therapeutic use
Oxidative Stress - drug effects
Risk Factors
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The benefits of drug treating hypertension, hyperglycemia and hyperlipidemias in terms of reduction of CVD morbidity and mortality are well established. However, there is epidemiological evidence that consumption of certain foods results to a reduction in myocardial infarction markers. Given in many reviews is the impact of dietary antioxidants pertained to LDL oxidation and to vascular endothelial dysfunction. The potential of a diet rich in these compounds on the management of hypertension, hyperglycemia and hyperlipidemias is hereby criticized. Although their clinical use not always translates into clinical benefit, data are motivating. In the future, these agents may be very important complementary treatment options for subjects with high risk for CVD.
ISSN:1043-6618
1096-1186
DOI:10.1016/j.phrs.2007.04.018